Collegium Pharmaceutical Inc

Most Recent

  • uploads///COLL
    Company & Industry Overviews

    What Collegium Pharmaceutical’s Valuation Trend Indicates

    Collegium Pharmaceutical’s (COLL) interest income increased from $137,000 in the second quarter of 2017 to $391,000 in the second quarter of 2018.

    By Kenneth Smith
  • uploads///COLL
    Company & Industry Overviews

    Surge in Xtampza Sales Bodes Well for Collegium Pharmaceutical

    Collegium Pharmaceutical generated total revenues of $73.06 million in the second quarter of 2018 as compared with $3.56 million in the second quarter of 2017.

    By Kenneth Smith
  • uploads///syringe _
    Company & Industry Overviews

    How Is Insys Therapeutics Positioned in H2 2018?

    Insys Therapeutics generated total revenues of $23.46 million in the second quarter of 2018 as compared to $42.58 million in the second quarter of 2017.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.